| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |